Neuromuscular complications following targeted therapy in cancer patients: beyond the immune checkpoint inhibitors. Case reports and review of the literature

INTRODUCTION: In the last years, many new drugs have been developed targeting different oncology pathways, overall improving both quality of life and survival in several malignancies. However, the increase of those therapies is associated with novel toxicities, mainly immune-related adverse events (...

Descripción completa

Detalles Bibliográficos
Autores principales: Demichelis, Chiara, Balestra, Andrea, Lapucci, Caterina, Zuppa, Angela, Grisanti, Stefano G, Prada, Valeria, Pesce, Giampaola, Grasso, Ilaria, Queirolo, Paola, Schenone, Angelo, Benedetti, Luana, Grandis, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955989/
https://www.ncbi.nlm.nih.gov/pubmed/32783159
http://dx.doi.org/10.1007/s10072-020-04604-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955989/
https://www.ncbi.nlm.nih.gov/pubmed/32783159
http://dx.doi.org/10.1007/s10072-020-04604-1

Ejemplares similares